Atlas Trials

An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer

Clinical trial NCT00532194 · UNKNOWN

Trial details

NCT number
NCT00532194
Sponsor
Medical Research Council
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2007-07-01
Primary completion
2013-04-01
Enrollment
486

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.